Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMXRYDL)

Drug Name

2-(5-Bromo-indole-1-sulfonyl)-benzoic acid Drug Info

Synonyms

CHEMBL184005; 2-(5-Bromo-indole-1-sulfonyl)-benzoic acid

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Patented Agent(s)

Download the Complete Related Drug List

Drug(s) Targeting Fatty acid-binding protein 4 (FABP4)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
PMID27109571-Compound-27	DMXRTH4	N. A.	N. A.	Patented	[2]
PMID27109571-Compound-31	DMU690T	N. A.	N. A.	Patented	[2]
PMID27109571-Compound-16	DMZI25U	N. A.	N. A.	Patented	[2]
PMID27109571-Compound-14	DMVY6B9	N. A.	N. A.	Patented	[2]
PMID27109571-Compound-25	DM435GR	N. A.	N. A.	Patented	[2]
PMID27109571-Compound-30	DM24FSP	N. A.	N. A.	Patented	[2]
PMID27109571-Compound-29	DMDMEHQ	N. A.	N. A.	Patented	[2]
PMID27109571-Compound-18	DM4S5ME	N. A.	N. A.	Patented	[2]
PMID27109571-Compound-28	DMTZVY3	N. A.	N. A.	Patented	[2]
PMID27109571-Compound-20	DMQU9XP	N. A.	N. A.	Patented	[2]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Fatty acid-binding protein 4 (FABP4)	TTHWMFZ	FABP4_HUMAN	Inhibitor	[1]

------------------------------------------------------------------------------------

References

1	Discovery of inhibitors of human adipocyte fatty acid-binding protein, a potential type 2 diabetes target. Bioorg Med Chem Lett. 2004 Sep 6;14(17):4445-8.
2	Fatty acid binding protein (FABP) inhibitors: a patent review (2012-2015).Expert Opin Ther Pat. 2016 Jul;26(7):767-76.